A
Arnaud Denis
Researcher at French Institute of Health and Medical Research
Publications - 104
Citations - 4343
Arnaud Denis is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Catheter ablation & Ventricular tachycardia. The author has an hindex of 31, co-authored 101 publications receiving 3506 citations. Previous affiliations of Arnaud Denis include Université Bordeaux Segalen & St. Jude Medical.
Papers
More filters
Journal ArticleDOI
Driver Domains in Persistent Atrial Fibrillation
Michel Haïssaguerre,Mélèze Hocini,Arnaud Denis,Ashok J. Shah,Yuki Komatsu,Seigo Yamashita,Matthew Daly,Sana Amraoui,Stephan Zellerhoff,Marie-Quitterie Picat,Adam Quotb,Laurence Jesel,Han S. Lim,Sylvain Ploux,Pierre Bordachar,Guillaume Attuel,Valentin Meillet,Philippe Ritter,Nicolas Derval,Frederic Sacher,Olivier Bernus,Hubert Cochet,Pierre Jaïs,Rémi Dubois +23 more
TL;DR: Persistent AF in early months is maintained predominantly by drivers clustered in a few regions, most of them being unstable reentries.
Journal ArticleDOI
Five-Year Outcome of Catheter Ablation of Persistent Atrial Fibrillation Using Termination of Atrial Fibrillation as a Procedural Endpoint
Daniel Scherr,Paul Khairy,Shinsuke Miyazaki,Valerie Aurillac-Lavignolle,Patrizio Pascale,Stephen B. Wilton,Khaled Ramoul,Yuki Komatsu,Laurent Roten,Amir Jadidi,Nick Linton,Michala Pedersen,Matthew Daly,Mark D O'Neill,Sébastien Knecht,Rukshen Weerasooriya,Thomas Rostock,Martin Manninger,Hubert Cochet,Ashok J. Shah,Sunthareth Yeim,Arnaud Denis,Nicolas Derval,Mélèze Hocini,Frederic Sacher,Michel Haïssaguerre,Pierre Jaïs +26 more
TL;DR: In patients with persistent AF, an ablation strategy aiming at AF termination is associated with freedom from arrhythmia recurrence in the majority of patients over a 5-year follow-up period.
Journal ArticleDOI
Outcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome
Frederic Sacher,Vincent Probst,Philippe Maury,Dominique Babuty,Jacques Mansourati,Yuki Komatsu,Christelle Marquié,Antonio Rosa,Abou Diallo,Romain Cassagneau,Claire Loizeau,Raphaël P. Martins,Michael E. Field,Nicolas Derval,Shinsuke Miyazaki,Arnaud Denis,Akihiko Nogami,Philippe Ritter,Jean-Baptiste Gourraud,Sylvain Ploux,Anne Rollin,Adlane Zemmoura,Dominique Lamaison,Pierre Bordachar,Bertrand Pierre,Pierre Jaïs,Jean-Luc Pasquié,Mélèze Hocini,Pascal Defaye,Serge Boveda,Yoshito Iesaka,Philippe Mabo,Michel Haïssaguerre +32 more
TL;DR: In this article, implantable cardioverter-defibrillator indications in Brugada syndrome remain controversial, especially in asymptomatic patients, and previous outcome data are limited by relatively small nu...
Journal ArticleDOI
Ablation of Persistent Atrial Fibrillation Targeting Low-Voltage Areas With Selective Activation Characteristics.
Amir Jadidi,Heiko Lehrmann,Cornelius Keyl,Jérémie Sorrel,Viktor Markstein,Jan Minners,Chan-il Park,Arnaud Denis,Pierre Jais,Mélèze Hocini,Clemens Potocnik,Juergen Allgeier,Willibald Hochholzer,Claudia Herrera-Siklody,Steve Kim,Youssef El Omri,Franz-Josef Neumann,Reinhold Weber,Michel Haïssaguerre,Thomas Arentz +19 more
TL;DR: Ablation of sites with distinct activation characteristics within/at borderzones of LVA in addition to PVI is more effective than conventional PVI-only strategy for persistent AF.
Journal ArticleDOI
High-power short-duration versus standard radiofrequency ablation: Insights on lesion metrics.
Felix Bourier,Josselin Duchateau,Konstantinos Vlachos,Anna Lam,Claire A. Martin,Masateru Takigawa,Takeshi Kitamura,Antonio Frontera,Ghassen Cheniti,Thomas Pambrun,Nicolas Klotz,Arnaud Denis,Nicolas Derval,Hubert Cochet,Frederic Sacher,Mélèze Hocini,Michel Haïssaguerre,Pierre Jaïs +17 more
TL;DR: The aim of this study was to analyze the influence of underlying parameters on lesion metrics of high‐power short‐duration (HPSD) and standard RF applications using an in silico and ex vivo model.